← Back to Search

Exercise Therapy for Prostate Cancer

Phase 2

Recruiting

Led By Lee Jones, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-12 months

Awards & highlights

Study Summary

This trial studies the effects of exercise therapy on indicators of prostate cancer in people with low-risk prostate cancer on active surveillance. Participants will be assigned walking on a treadmill or their usual exercise routines. No treatment is provided.

Who is the study for?

This trial is for men over 18 with low-risk prostate cancer who are under active surveillance, not very active (exercising less than 150 minutes per week), have a BMI below 40, and pass an exercise safety check. It's not for those on other treatments or programs that affect tumor outcomes, with any history of systemic anticancer therapy or distant metastatic malignancy.Check my eligibility

What is being tested?

The study tests the effects of home-based treadmill walking sessions designed by an exercise physiologist against usual exercise routines in managing indicators of prostate cancer. Participants will either follow the assigned walking program or continue their regular exercises to see which has a better impact on prostate health.See study design

What are the potential side effects?

Since this trial involves exercise therapy rather than medication, side effects may include typical physical activity-related issues such as muscle soreness, fatigue, joint pain or injury risk. However, these are generally mild and manageable.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in molecular, radiologic, and pathologic nimbosus hallmarks from baseline to follow-up

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Participants Assigned to Exercise TherapyExperimental Treatment1 Intervention

Participants with histologically confirmed localized prostate cancer undergoing active surveillance

Group II: Participants Assigned to Usual CareActive Control1 Intervention

Participants with histologically confirmed localized prostate cancer undergoing active surveillance

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise Therapy

2013

Completed Phase 3

~750

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,935 Previous Clinical Trials

588,759 Total Patients Enrolled

132 Trials studying Prostate Cancer

51,972 Patients Enrolled for Prostate Cancer

Lee Jones, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

7 Previous Clinical Trials

5,419 Total Patients Enrolled

1 Trials studying Prostate Cancer

70 Patients Enrolled for Prostate Cancer

Media Library

Exercise Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05751434 — Phase 2

Prostate Cancer Research Study Groups: Participants Assigned to Usual Care, Participants Assigned to Exercise Therapy

Prostate Cancer Clinical Trial 2023: Exercise Therapy Highlights & Side Effects. Trial Name: NCT05751434 — Phase 2

Exercise Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05751434 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the U.S. Food and Drug Administration endorsed Participants Assigned to Exercise Therapy?

"Per our team's evaluation, the safety of Participants Assigned to Exercise Therapy scored a 2 on the 1-3 scale due to its Phase 2 status. Evidence for safety has been collected but there is no verifiable data regarding efficacy."

Answered by AI

How many healthcare centers are currently undertaking this experiment?

"Presently, 8 trial sites are operational for this medical exploration. These include Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) in Basking Ridge, Memorial Sloan Kettering Monmouth (Limited protocol activities) in Middletown and Memorial Sloan Kettering Bergen (Limited protocol activities) in Montvale to name a few."

Answered by AI

Are individuals being recruited for this clinical experiment presently?

"Affirmative. As per the clinicaltrials.gov database, this research is currently open to new participants and was first announced on February 10th 2023 before being updated on February 20th 2023. 102 individuals need to be enlisted across 8 study sites."

Answered by AI

How many participants is this experiment seeking to recruit?

"To effectively carry out this research, 102 individuals that fit the predetermined eligibility criteria need to partake in the trial. Participants can enrol at Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) located in New jersey and Memorial Sloan Kettering Monmouth (Limited protocol activities) found in Middletown, NY respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

2023. "A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05751434.